Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Circulating Tumor DNA in Patients With Early Stage Breast Cancer

NCT04353557 is registered in ClinicalTrials.gov with Geneplus-Beijing Co. Ltd. as lead sponsor.

NCT NCT04353557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04353557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Circulating Tumor DNA in Patients With Early Stage Breast Cancer
Lead sponsor
Geneplus-Beijing Co. Ltd.
Phase
Observational
Overall status
Recruiting
Start date
November 29, 2019
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer